Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Edwards Lifesciences
(NY:
EW
)
71.53
+0.33 (+0.46%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Edwards Lifesciences
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
17
18
Next >
Why Edwards Lifesciences Stock Plummeted Today
October 26, 2023
Investors trade on potential rather than trailing results, and they found the company's top-line guidance wanting.
Via
The Motley Fool
Earnings Scheduled For October 25, 2023
October 25, 2023
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion.
Via
Benzinga
US Stocks Poised For Mixed Start Ahead Of Meta Earnings: Analyst Sees Corporate Profits Providing 'Fundamental Ballast' To Market
October 25, 2023
With numerous headwinds in play, analysts have stressed the importance of robust corporate profit growth to sustain valuations.
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
October 24, 2023
Via
Benzinga
How Is The Market Feeling About Edwards Lifesciences?
October 24, 2023
Via
Benzinga
P/E Ratio Insights for Edwards Lifesciences
October 12, 2023
Via
Benzinga
How Is The Market Feeling About Edwards Lifesciences?
October 06, 2023
Via
Benzinga
Expert Ratings for Edwards Lifesciences
October 02, 2023
Via
Benzinga
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market?
October 23, 2023
Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
$1000 Invested In This Stock 15 Years Ago Would Be Worth $15,000 Today
September 15, 2023
Via
Benzinga
Looking Into Edwards Lifesciences's Recent Short Interest
September 14, 2023
Via
Benzinga
Expert Ratings for Edwards Lifesciences
September 08, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years
October 19, 2023
Via
Benzinga
Edwards Lifesciences Faces European Scrutiny Over Patent Policies, Copycat Devices
October 17, 2023
U.S. medical devices manufacturer Edwards Lifesciences Corp (NYSE: EW) is reportedly under the scrutiny of EU antitrust regulators for its patent practices and policies aimed at thwarting copycat...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Here's How Much $100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today
September 28, 2023
Via
Benzinga
Edwards Lifesciences Commits to Fair Competition Amid Regulatory Scrutiny, Analyst Upgrades Stock
September 26, 2023
The European Commission conducted a surprise inspection at Edwards Lifesciences Corp's (NYSE: EW) facility within a European Union member state due to suspicions of potential market power abuse,...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2023
September 26, 2023
Via
Benzinga
Analyst Ratings for Edwards Lifesciences
August 17, 2023
Via
Benzinga
(EW) - Analyzing Edwards Lifesciences's Short Interest
August 15, 2023
Via
Benzinga
Cramer Says 'I Have No Idea What's Happening' To A Once-Favored Stock Down 35% YTD
September 13, 2023
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Edwards Lifesciences Corporation (NYSE: EW) used to be "one of the greatest stocks of our time and, it’s now
Via
Benzinga
Patients With Deadly Heart Disease Underdiagnosed, Including 66% of Women: AI-Powered Clinical Study Shows
September 08, 2023
Via
Get News
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why Analysts Say GE's Healthcare Spinoff Has $20 Upside
September 05, 2023
General Electric’s spinoff, GE HealthCare Technologies Inc., is delivering some impressive results and has growth opportunities well worth tuning in to.
Via
MarketBeat
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 10 Years
August 31, 2023
Via
Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,600 Today
August 11, 2023
Via
Benzinga
Where Edwards Lifesciences Stands With Analysts
August 01, 2023
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $700 Today
July 28, 2023
Via
Benzinga
Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains
August 30, 2023
The demand for healthcare devices and tools are increasing which means their stocks will provide profits for investors.
Via
InvestorPlace
Barron's Weekend Stock Picks: PayPal, Nikola And Icahn Enterprises' Challenges
August 05, 2023
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.
Via
Benzinga
Why Willis Towers Watson Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
July 27, 2023
Gainers Femasys Inc. (NASDAQ: FEMY) gained 54% to $0.55. Femasys reported a notice of allowance for new U.S. patent application covering use of FemBloc for female permanent birth control.
Via
Benzinga
US Stocks Buckle Up For Solid Open On Meta's Earnings Boost, Fed Relief — But Analyst Advises Some 'Value-Style' Rebalancing
July 27, 2023
Stocks could be heading to a higher open on Thursday, as traders digest some positive earnings reports and look ahead to another batch of economic data.
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
17
18
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.